Results 81 to 90 of about 7,168 (203)

Targeting antibiotic resistance [PDF]

open access: yes, 2016
Finding strategies against the development of antibiotic resistance is a major global challenge for the life sciences community and for public health.
Chellat, Mathieu F.   +2 more
core   +1 more source

Epidemiology, Treatment, and Outcomes of Gram‐Negative Bacteremia in a Multicenter Cohort of Solid Organ Transplant Recipients

open access: yesClinical Transplantation, Volume 39, Issue 4, April 2025.
ABSTRACT Introduction Little is known about the epidemiology and management of gram‐negative bloodstream infections (GN‐BSIs) in patients after solid organ transplant (SOT). We describe epidemiology, treatment approaches, and outcomes in a subset of patients with SOT from a larger cohort with GN‐BSI. Methods This was a multicenter, retrospective cohort
Sarah B. Doernberg   +11 more
wiley   +1 more source

Establishing discordance rate of estimated glomerular filtration rate between serum creatinine‐based calculations and cystatin‐C‐based calculations in critically ill patients

open access: yesPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, Volume 45, Issue 3, Page 161-168, March 2025.
Abstract Introduction The use of serum creatinine (SCr) for drug dosing has significant limitations and is influenced by many non‐kidney factors. Cystatin C (cysC) is an alternative or additional marker of kidney function that is less affected by non‐kidney factors. Although cysC may be useful in hospitalized patients, the use of cysC to calculate drug
Victoria L. Williams, Anthony T. Gerlach
wiley   +1 more source

Antimicrobial options for methicillin-resistant Staphylococcus aureus pyogenic infections: an in vitro comparison of ceftaroline, vancomycin, and linezolid

open access: yesMGM Journal of Medical Sciences
Background: The increase in methicillin-resistant Staphylococcus aureus (MRSA)-related pyogenic infections emphasizes the need for new treatment options.
Swati Saxena   +4 more
doaj   +1 more source

Veterinary Medicine Needs New Green Antimicrobial Drugs [PDF]

open access: yes, 2016
Given that: (1) the worldwide consumption of antimicrobial drugs (AMDs) used in food-producing animals will increase over the coming decades; (2) the prudent use of AMDs will not suffice to stem the rise in human antimicrobial resistance (AMR) of animal ...
Adams   +97 more
core   +5 more sources

Complicated and deep bacterial skin and soft tissue infections

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 23, Issue 3, Page 357-375, March 2025.
Summary Complicated erysipelas, cellulitis, and necrotizing soft tissue infections belong to the spectrum of bacterial infections affecting the skin and underlying soft tissues. Their frequency as well as risk of recurrence and complicated disease course pose a significant health burden.
Christine Prodinger   +7 more
wiley   +1 more source

Bicarbonate Resensitization of Methicillin-Resistant Staphylococcus aureus to β-Lactam Antibiotics. [PDF]

open access: yes, 2019
Endovascular infections caused by methicillin-resistant Staphylococcus aureus (MRSA) are a major health care concern, especially infective endocarditis (IE).
Abdelhady, Wessam   +5 more
core  

Beyond conventional antibiotics for the future treatment of methicillin-resistant Staphylococcus aureus infections: two novel alternatives. [PDF]

open access: yes, 2012
The majority of antibiotics currently used to treat methicillin-resistant Staphylococus aureus (MRSA) infections target bacterial cell wall synthesis or protein synthesis. Only daptomycin has a novel mode of action.
Devocelle, Marc   +2 more
core   +1 more source

Addition of ceftaroline fosamil or vancomycin to PMMA: An in vitro comparison of biomechanical properties and anti-MRSA efficacy

open access: yesJournal of Orthopaedic Surgery, 2019
Background: Ceftaroline is a cephalosporin that is effective against methicillin-resistant Staphylococcus aureus (MRSA) infections. The objective of this study was to determine the feasibility of using ceftaroline-loaded Polymethyl methacrylate (PMMA) as
Amber Haseeb   +3 more
doaj   +1 more source

Antimicrobial Resistance (AMR) and Multidrug Resistance (MDR): Overview of Current Approaches, Consortia and Intellectual Property Issues [PDF]

open access: yes, 2017
The supply of new diagnostics and treatments is insufficient to keep up with the increase in antimicrobial resistance (AMR) and multidrug resistance (MDR) as older medicines are used more widely and microbes develop resistance to them.
Bhagwandin, Niresh   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy